NCT05849298
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05849298
Title A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC (PSMACare)
Acronym PSMACare
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | FRA | ESP | DEU | CZE | CAN | BRA

Facility Status City State Zip Country Details
Urology Associates of Mobile Mobile Alabama 36608 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
University Of Florida Jacksonville Florida 32218 United States Details
University Cancer and Blood Center LLC Athens Georgia 30607 United States Details
Urology Of Indiana Indianapolis Indiana 46254 United States Details
Unity Point Clinic Des Moines Iowa 50323 United States Details
Urology Cancer Center PC Omaha Nebraska 68130 United States Details
Associated Med Professionals of NY Syracuse New York 13210 United States Details
Oregon Urology Institute Springfield Oregon 97477 United States Details
Wellspan York Hospital York Pennsylvania 17403 United States Details
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 United States Details
Urology Clinic of North Texas Dallas Texas 75231 United States Details
Univ of Texas Southwest Med Center Dallas Texas 75390-9034 United States Details
Rio Grande Urology El Paso Texas 79912 United States Details
Houston Methodist Hospital Houston Texas 77030 United States Details
UT Health San Antonio Mays Cancer Center San Antonio Texas 78229 United States Details
Novartis Investigative Site São Paulo São Paulo 01308-050 Brazil Details
Novartis Investigative Site São Paulo São Paulo 05652-000 Brazil Details
Novartis Investigative Site Halifax Nova Scotia B3H 2Y9 Canada Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Montreal Quebec H2X 1R9 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Nanjing Jiangsu 210029 China Details
Novartis Investigative Site Beijing 100028 China Details
Novartis Investigative Site Olomouc 779 00 Czechia Details
Novartis Investigative Site Angers 49055 France Details
Novartis Investigative Site Brest 29609 France Details
Novartis Investigative Site Caen 14021 France Details
Novartis Investigative Site Paris 75014 France Details
Novartis Investigative Site Strasbourg 67200 France Details
Novartis Investigative Site Cologne North Rhine-Westphalia 50937 Germany Details
Novartis Investigative Site Berlin 10249 Germany Details
Novartis Investigative Site Rostock 18057 Germany Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milan MI 20141 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Arnhem Gelderland 6815 AD Netherlands Details
Novartis Investigative Site Kielce 25-640 Poland Details
Novartis Investigative Site Krakow 30-688 Poland Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Granada Andalusia 18014 Spain Details
Novartis Investigative Site L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Novartis Investigative Site Vigo Pontevedra 36212 Spain Details
Novartis Investigative Site Barcelona 08036 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field